The progression of CRC in a metastatic stage was inhibited via the induction of lipocalin2 (LCN2) and the concomitant inhibition of the NF-κB/snail signaling pathway, which promotes EMT, migration, and invasion in CRC [52]. This evidence concerns the gene SNAI1 and colorectal carcinoma.